Crinetics Pharmaceuticals CRNX
CRNX
$84.95 +0.00 (+0.00%)
At close: Sep 2, 2026 · 4:00 PM EDT

Crinetics Pharmaceuticals (CRNX) Accumulated Expenses (2017 - 2019)

Updated

Crinetics Pharmaceuticals (CRNX) posted Accumulated Expenses of $3.18 million for Q3 2019, down 22.8% from $4.12 million a year earlier and down 2.0% from the prior quarter.

Analysis

Crinetics Pharmaceuticals (CRNX) Accumulated Expenses (2017 - 2019) Analysis & Trends

At the end of FY2018, Crinetics Pharmaceuticals' Accumulated Expenses came in at $4.19 million.

  • In prior years, Crinetics Pharmaceuticals' Accumulated Expenses was $179,000 in FY2017.
  • The Q3 2019 figure stands as the lowest quarterly Accumulated Expenses since Q2 2018.
  • According to Business Quant data, Accumulated Expenses for the three prior quarters was $3.24 million (Q2 2019), $5.3 million (Q1 2019) and $4.19 million (Q4 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Crinetics Pharmaceuticals 8.99 Bn 8.99 Bn 24.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 3.18 Mn
Jun 30, 2019 3.24 Mn
Mar 31, 2019 5.30 Mn
Dec 31, 2018 4.19 Mn
Sep 30, 2018 4.12 Mn
Jun 30, 2018 3.04 Mn
Dec 31, 2017 179,000.00
API Access

Crinetics Pharmaceuticals Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CRNX&period=max&api_key=YOUR_API_KEY